This is my first visit here. I don't see why the stock dropped on the recent fund raising dilution. I don't see many shares to begin with (EDIT: OK pink sheets is showing me a recent filing with huge OS, so I guess I need to dig deeper here...OK the last SEC filing this week says: 38,361,674 shares outstounding, that makes for a huge market cap at todays price so I am missing something), and with a $1 million dollar fund raising at only .80, that still leaves a tiny OS. Am I missing something here? And I read in a newsletter today that the CEO here, is the NVS ex-ceo? If this is right, this stock is incredibly cheap, overlooked, unloved and ripe for the picking. Only a $1 million dollar market cap for a biotech? And currently selling for 25% of its 52 week high? And with insider buying too!
Market Data 
Markets 
AI
